Answers are grounded in this paper and cite their sources.
It is well known that the serious systemic changes in acromegaly resulting from excess GH-secretion, and for that reason, treatment is vital. Trans-sphenoidal adenectomy has typically been the accepted initial treatment of choice for most patients with acromegaly. However, the prediction of postoperative disease activity is a major challenge, and even though different criteria for a cure have been suggested and the relationship between these criteria and long-term disease control is still controversial. According to the criteria for cure of Acromegaly-Consensus, Baseline biochemical parameters for the diagnosis of acromegaly include a fasting or random GH and IGF measurement. If a random GH level is less than 0.4 g/L and IGF is in the age-and gender-matched normal range, the diagnosis of acromegaly is excluded. If either of these levels is not achieved, a glucose tolerance test should be performed, the GH level should fall to 1 g/L or less for acromegaly to be excluded.
No takes yet. Share an insight, caveat, or question.
Fawaz Assaad (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: